71 related articles for article (PubMed ID: 35715142)
1. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin protease expression in infiltrative soft tissue sarcomas: cathepsin-K correlates with infiltrative tumor growth and clinical outcomes.
Fujiwara T; Zhang L; Chandler A; Sung S; Yakoub M; Linkov I; Hameed M; Healey JH
Hum Pathol; 2023 Apr; 134():30-44. PubMed ID: 36565726
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA; Vegas I; El-Senduny FF; Zhang J; Mata DA; Hiemenz MC; Hughes SR; Sa BC; Kraft GP; Gorbatov N; Foley-Peres K; Sanchez EZ; Milikowski C; Williams KJ; Ross JS; Kurzrock R; Montgomery EA; Lombard DB; Kumar S
Am J Surg Pathol; 2024 Jun; 48(6):699-707. PubMed ID: 38369783
[TBL] [Abstract][Full Text] [Related]
4. Recurrent neck myxofibrosarcoma: a case report.
Pagnoni C; Improta L; Alloni R; Mallozzi Santa Maria F; Aprile I; Brunetti B; Greco C; Vincenzi B; Gronchi A; Valeri S
J Med Case Rep; 2021 Oct; 15(1):484. PubMed ID: 34593019
[TBL] [Abstract][Full Text] [Related]
5. The devastating impact of unresectable infectious undifferentiated pleomorphic sarcoma in the gluteal region: A case report.
Goli R; Torabzadeh A; Hassanpour A; Jafarimaraghoush A; Manouchehri E; Faraji N
Int J Surg Case Rep; 2024 May; 118():109592. PubMed ID: 38552374
[TBL] [Abstract][Full Text] [Related]
6. Primary undifferentiated pleomorphic sarcoma (Malignant fibrous histiocytoma) of the lung: A case report.
Miyashita Y; Ikeda N; Hiraoka K
Clin Case Rep; 2020 Jan; 8(1):33-37. PubMed ID: 31998481
[TBL] [Abstract][Full Text] [Related]
7. Undifferentiated Pleomorphic Sarcoma of the Distal Thigh: A Case Report.
AlShaya OS; Alanazi SR; Alshaghathirah FM
Cureus; 2024 Apr; 16(4):e58685. PubMed ID: 38774184
[TBL] [Abstract][Full Text] [Related]
8. A huge left buttock mass in an old female.
Farida A; Yudy C; Elias S
J Orthop; 2024 Aug; 54():116-119. PubMed ID: 38560592
[TBL] [Abstract][Full Text] [Related]
9. Development and external validation of a machine learning model for prediction of survival in undifferentiated pleomorphic sarcoma.
Lee L; Yi T; Fice M; Achar RK; Jones C; Klein E; Buac N; Lopez-Hisijos N; Colman MW; Gitelis S; Blank AT
Musculoskelet Surg; 2024 Mar; 108(1):77-86. PubMed ID: 37658174
[TBL] [Abstract][Full Text] [Related]
10. High Grade Myxofibrosarcoma of Maxillary Sinus: A Case Report and Review of Literature.
Malhotra S; Negi P
Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):269-277. PubMed ID: 37206853
[TBL] [Abstract][Full Text] [Related]
11. Small-intestine undifferentiated pleomorphic sarcoma presenting as intestinal obstruction: A case report.
Zhou B; Li X; Peng L; Duan T
Asian J Surg; 2024 Apr; 47(4):1813-1814. PubMed ID: 38145915
[No Abstract] [Full Text] [Related]
12. The ultrasonography and pathological features of primary hepatic pleomorphic undifferentiated sarcoma.
Bao Y; Meng Q; Qu N
Med Ultrason; 2024 Mar; 26(1):99-100. PubMed ID: 38537191
[No Abstract] [Full Text] [Related]
13. Myxofibrosarcoma of the leg: A diagnostic challenge.
Rachdi I; Daoud F; Khanchel F; Arbaoui I; Somai M; Zoubeidi H; Aydi Z; Ben Dhaou B; Debbiche A; Boussema F
Clin Case Rep; 2020 Dec; 8(12):3333-3336. PubMed ID: 33363928
[TBL] [Abstract][Full Text] [Related]
14. Undifferentiated Pleomorphic Sarcoma of the Face.
Brown E; Rahimi C; Gupta ND; Gupta JD; Do TM; Igi M; Palacios E
Ear Nose Throat J; 2024 May; ():1455613241252890. PubMed ID: 38721819
[No Abstract] [Full Text] [Related]
15. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.
Sun H; Liu J; Hu F; Xu M; Leng A; Jiang F; Chen K
Front Genet; 2023; 14():1109491. PubMed ID: 36873946
[TBL] [Abstract][Full Text] [Related]
16. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
Vanni S; De Vita A; Gurrieri L; Fausti V; Miserocchi G; Spadazzi C; Liverani C; Cocchi C; Calabrese C; Bongiovanni A; Riva N; Mercatali L; Pieri F; Casadei R; Lucarelli E; Ibrahim T
Ther Adv Med Oncol; 2022; 14():17588359221093973. PubMed ID: 35782752
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
Vanni S; Fausti V; Fonzi E; Liverani C; Miserocchi G; Spadazzi C; Cocchi C; Calabrese C; Gurrieri L; Riva N; Recine F; Casadei R; Pieri F; Guerrieri AN; Serra M; Ibrahim T; Mercatali L; De Vita A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108089
[TBL] [Abstract][Full Text] [Related]
18. A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma.
Graves L; Jeck WR; Grilley-Olson JE
Curr Treat Options Oncol; 2023 Mar; 24(3):212-228. PubMed ID: 36729198
[TBL] [Abstract][Full Text] [Related]
19. UNDIFFERENTIATED PLEOMORPHIC SARCOMA: PROGNOSTIC FACTORS IN 42 EXTREMITY CASES.
Maçaneiro CH; Baptista AM; Camargo OP; Filippi RZ; Oliveira ET
Acta Ortop Bras; 2023; 31(2):e265942. PubMed ID: 37151725
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
